D. Bigner

Publications875
h-index117
Citations78,972
Highly Influential Citations3,159
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • H. Friedman
  • 835 Publications • 53,222 Citations
  • R. McLendon
  • 455 Publications • 56,531 Citations
  • J. Sampson
  • 535 Publications • 26,230 Citations
  • M. Zalutsky
  • 464 Publications • 15,014 Citations
  • Publications
  • Influence
Mutations of the BRAF gene in human cancer
TLDR
BRAF somatic missense mutations in 66% of malignant melanomas and at lower frequency in a wide range of human cancers, with a single substitution (V599E) accounting for 80%.
View on Springer
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
TLDR
This work shows that cancer stem cells contribute to glioma radioresistance through preferential activation of the DNA damage checkpoint response and an increase in DNA repair capacity, and suggests that CD133-positive tumour cells could be the source of tumour recurrence after radiation.
View on Nature
The Somatic Genomic Landscape of Glioblastoma
View on Elsevier
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
TLDR
Recurrent mutations in the active site of isocitrate dehydrogenase 1 (IDH1) occurred in a large fraction of young patients and in most patients with secondary GBMs and were associated with an increase in overall survival.
View on Publisher
The Immune Landscape of Cancer
View on Wolters Kluwer
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
TLDR
The integration of genomewide data from multiple platforms delineated three molecular classes of lower-grade gliomas that were more concordant with IDH, 1p/19q, and TP53 status than with histologic class.
View on PubMed
Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor.
TLDR
Data indicate that stem cell-like tumor cells can be a crucial source of key angiogenic Factors in cancers and that targeting proangiogenic factors from stem cell -like tumor populations may be critical for patient therapy.
View on PubMed
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
TLDR
TERT and ATRX mutations were mutually exclusive, suggesting that these two genetic mechanisms confer equivalent selective growth advantages and provide a biomarker that may be useful for the early detection of urinary tract and liver tumors and aid in the classification and prognostication of brain tumors.
View on Publisher
Altered Telomeres in Tumors with ATRX and DAXX Mutations
TLDR
The data suggest that an alternative telomere maintenance function may operate in human tumors with alterations in the ATRX or DAXX genes, which are common in human pancreatic neuroendocrine tumors.
View on Publisher
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
TLDR
The genetic signatures distinguished clinically distinct groups of oligoastrocytoma patients, which usually present a diagnostic challenge, and were associated with differences in clinical outcome even among individual tumor types.
View PDF
...
...